HealthManagement, Volume 18 - Issue 1, 2018

Reinventing breast tomosynthesis

share Share

Expanding Leadership based on clinical evidence.


In early September, Hologic launched the new 3Dimensions™ mammography system, a breast tomosynthesis system with the fastest and highest resolution, in EMEA. I recently had the pleasure of showcasing this cutting-edge device at the European Society of Breast Imaging (EUSOBI) Annual Scientific Meeting, where a number of radiologists from a variety of regions congregated.

The Hologic team conducted robust research that revealed clinicians across Europe continue to emphasise the importance of accuracy, clarity, dose  and workflow when it comes to breast imaging devices. Fortunately, the 3Dimensions system features are designed to specifically address those areas of interest. The system’s Clarity HD high-resolution 3D™ imaging, which reduces recalls by up to 40 percent compared to 2D alone, provides the industry's fastest, highest resolution 3D images to accelerate screening and analysis. In addition, the 3Dimensions system offers intelligent 2D™ imaging technology, which works with Clarity HD technology to deliver unprecedented clarity, contrast and detail at a lower dose. Intelligent 2D imaging technology features smart mapping, which enables radiologists to instantly move from suspicious areas detected on the 2D image to the point of interest on the 3D slice, saving time and optimising workflow. Finally, with the help of its intelligent 2D imaging technology, the 3Dimensions system results in a 45 percent dose reduction with a generated 2D image compared to 2D FFDM alone.

Hologic’s 3D Mammography™ exam , which detects up to 65 percent more invasive breast cancers and is the only mammogram approved by the U.S. Food and Drug Administration as superior for women with dense  breasts compared to 2D alone, is available on the 3Dimensions system. The 3Dimensions system is already installed in several sites in Europe, and it is a truly exciting step forward in Hologic’s ongoing efforts to innovate breast screening technology that meets both clinicians’ and patients’ needs across the globe.
 
As a woman who participates in breast cancer screening and is passionate about ensuring women have access to the best technology available, I know first-hand how important it is to develop equipment that factors in insights from both radiologists and patients to improve the experience. These insight-driven advancements in technology must be supported by strong clinical evidence, and I look forward to continuing the work on the next innovations that aim to do just that from Hologic.
 

Disclosure: “Point of View” articles are part of the HealthManagement.org Corporate Engagement Programme.



Related Articles

No refunds or returns for advanced disease Without a shift to a personalised breast cancer screening programme, participation... Read more

Radiologists collaborate with sports physicians for optimal performance How diagnostic imaging can be used in sports medicine... Read more

New book to provide a roadmap for optimisation In a soon-to-be released book, experts offer their knowledge and guidance... Read more

Tomosynthesis, Leadership, EUSOBI, Hologic, Radiologists, mammogram, Breast tomosynthesis, Breast Cancers, 3D Mammography™ exam, Lori Fontaine, 3Dimensions™, Hologic 3Dimensions™ Mammography, clinical evidence, 3Dimensions™ mammography, 3Dimensions™ mammography s ystem, Clarity HD high-resolution 3D™ imaging, Intelligent 2D™ imaging technology Expanding Leadership based on clinical evidence.

No comment


Please login to leave a comment...

Highlighted Products